170 related articles for article (PubMed ID: 3469189)
1. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
Reutter FW
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
Garau J; Casagrán A; Sánchez C; Matas E
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
[TBL] [Abstract][Full Text] [Related]
4. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
Baruchel A; Hartmann O; Andremont A; Tancrède C
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
[TBL] [Abstract][Full Text] [Related]
5. Imipenem-cilastatin as initial therapy for febrile cancer patients.
Bodey GP; Alvarez ME; Jones PG; Rolston KV; Steelhammer L; Fainstein V
Antimicrob Agents Chemother; 1986 Aug; 30(2):211-4. PubMed ID: 3532942
[TBL] [Abstract][Full Text] [Related]
6. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
Calandra GB; Hesney M; Brown KR
Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
[TBL] [Abstract][Full Text] [Related]
7. Imipenem/cilastatin therapy of infections in cancer patients.
Bodey GP; Elting L; Jones P; Alvarez ME; Rolston K; Fainstein V
Cancer; 1987 Jul; 60(2):255-62. PubMed ID: 3297282
[TBL] [Abstract][Full Text] [Related]
8. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
Wang C; Pappas F; Cook T
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
[TBL] [Abstract][Full Text] [Related]
9. Imipenem/cilastatin for the treatment of infections in hospitalized children.
Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
[TBL] [Abstract][Full Text] [Related]
10. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
Unertl K; Lenhart FP; Ruckdeschel G
Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
[TBL] [Abstract][Full Text] [Related]
13. Primaxin in the treatment of acute bacterial pneumonia in adults.
Gebhart RJ; Duma RJ; Patterson PM; Bagett JW; Williams DS
J Antimicrob Chemother; 1985 Feb; 15(2):233-8. PubMed ID: 3980311
[TBL] [Abstract][Full Text] [Related]
14. Imipenem/cilastatin in the treatment of severe hospital infections.
Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
[TBL] [Abstract][Full Text] [Related]
15. Experience with imipenem/cilastatin in the intensive care unit.
Rouveix E; Bure AM; Regnier B; Wolff M; Pangon B; Laisne MJ; Vachon F
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():153-60. PubMed ID: 3469188
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
Giamarellou H; Sfikakis P; Voutsinas D; Galanakis N; Daikos GK
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():175-9. PubMed ID: 3469191
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
Zajac BA; Fisher MA; Gibson GA; MacGregor RR
Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187
[TBL] [Abstract][Full Text] [Related]
19. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
Calandra GB; Ricci FM; Wang C; Brown KR
J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pneumonia with imipenem/cilastatin.
Beasley CR; Humble MW; O'Donnell TV
N Z Med J; 1985 Jun; 98(781):494-7. PubMed ID: 3859775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
